Navigation Links
Do the Swiss Have the Answer to America's Health Care Dilemma?
Date:7/31/2009

EDWARDSVILLE, Ill., July 31 /PRNewswire-USNewswire/ -- With the health care debate heating up in Washington, and with no apparent solution in sight, it has been suggested that America might want to take a page from the Swiss playbook.

In a nutshell:

  • Switzerland has a mandate requiring everyone to be covered by private insurance.
  • Poor people are subsidized as necessary to meet the mandate.
  • There is no employer-provided or government-managed coverage.
  • Sick persons pay the same price for health insurance as healthy persons in the same demographic category.

According to its proponents, the Swiss system results in health care which is comparable to that in the most affluent U.S. states, while its per capita health costs are 40 percent lower than in the U.S.

Switzerland currently has 80-plus separate health plans competing for business, from which Swiss citizens can freely choose. The government's primary (if not only) role is to subsidize lower-income people.

A primary advantage of such a consumer-controlled system, proponents say, is that it spreads risk across the full population spectrum, thereby lowering loss ratios and enabling lower premiums. It also keeps a proven health care delivery system in place, which government-controlled plans would necessarily disrupt.

Opponents to such a free market health idea argue that choosing the right medical insurance plan is too complicated for ordinary citizens to understand or navigate.

When asked, Vicki Rolens, managing director of the Federation of American Consumers and Travelers (FACT), says that the consumer association neither supports nor opposes the "Swiss Solution." "However," she says, "we do believe, when it comes to a matter as important as health care, that everyone should seriously consider all the possible avenues which might be taken. We think this is particularly true of an avenue which has apparently been successfully traveled elsewhere."

FACT is a nonpartisan not-for-profit corporation, formed a quarter-century ago in the District of Columbia. The group furnishes information of interest and importance to the American consumer without any political bias or hidden agenda. "We urge everyone who has a particular viewpoint concerning this or any consumer-related issue to share it with us," says Rolens. "We will in turn share it with the decision-makers in Washington, and with our members nationwide."

The association currently serves more than 1 million consumers in all 50 states.

This news release is issued as a service of the Federation of American Consumers and Travelers (FACT). Additional information on FACT may be found in the Encyclopedia of Associations, and by visiting the association's Web site (http://www.usafact.org). Informative, unbiased news bulletins are regularly disseminated by FACT to help its members remain current on matters which might seriously impact their lives. In addition to publishing consumer-related reports, the association provides more than 30 benefits for its members, ranging from dental discounts and prescription drug savings to scholarships and roadside assistance. FACT's administrative office is located at 318 Hillsboro Avenue, Edwardsville, IL 62025.

    Contact:

    Vicki Rolens
    800-USA-FACT
    cservice@usafact.org

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Federation of American Consumers and Travelers
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. EMH Swiss Medical Publisher Ltd. Selects Editorial Manager for Online Peer Review
2. Swissray Awarded US Government Contract
3. Swiss Res Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans
4. Swiss Medical Group Selects ILog JRules to Streamline Claims Processing
5. Swiss Institute of Bioinformatics announces major breakthrough
6. Swiss Systems Biology Initiative announces Flagship Projects
7. First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II
8. Swiss study suggests surgery may offer best chance of long-term prostate cancer survival
9. Allsup Answers Common Questions People Have About Social Security Disability
10. Max Muscle Sports Nutrition Answers Call For Safe Science-Based Weight Loss
11. A Bundle of Joy Brings a Bundle of Questions - Life123.com Delivers the Answers!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... , ... Axiad IDS , a leading provider of trusted identities for ... company a “Top 25 Cybersecurity Companies 2017.” Axiad IDS received this honor ... proactively address potential cybersecurity threats before they happen. The annual list of ...
(Date:5/23/2017)... ... , ... New England Journal Of Medicine Confirms Viability of Rory’s Regulations and ... Staunton Foundation Calls on Health & Human Services, Tom Price to Adopt Rory’s Regulations ... today reported on a new study released on May 21, 2017 in the New ...
(Date:5/23/2017)... ... 23, 2017 , ... The Gallery of Cosmetic Surgery, founded ... to announce a new treatment option called Vivace Microneedling. This treatment option is ... body through a virtually pain-free, non-surgical treatment. Vivace Microneedling combines a state-of-the-art, best-in-class ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... video chat as a standard feature on its secure clinical communication platform. The ... voice to video depending on the type and urgency of a situation. ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... treatment using the SPEED System™ Orthodontics, with or without a referral, from the ... in El Segundo, CA, who is skilled in providing patients with the custom, ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... MAITLAND, Fla. , May 22, 2017 /PRNewswire/ ... industry as a whole continue to make the ... evidence becomes increasingly important for ensuring positive patient ... Key industry stakeholders are shifting focus away from ... results and effects of long-term specialty drug therapy ...
(Date:5/18/2017)... N.J. , May 17, 2017  Bayer announced ... oncology portfolio will be presented at the 53 rd ... Oncology (ASCO), taking place June 2-6 in ... presented at ASCO span prostate, colorectal, liver and thyroid ... analysis from the Phase II CHRONOS-1 trial of copanlisib ...
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based ... to treat Parkinson,s disease (PD), has enrolled the first patient ... randomized, controlled, multicenter study involving patients with PD and taking ... over a 9-to-12-month period. The first stage is open label ... Participating sites include Denver , ...
Breaking Medicine Technology: